glp 1 agonist drug list America's Poison Centers glp 1 and glp 2

doi: 10.1038/344879a0

Once daily injectable liraglutide (marketed as Victoza for T2DM and Saxenda for obesity) and once weekly injectable semaglutide (marketed as Ozempic for T2DM and Wegovy for obesity) are two additional GLP-1 analogues, sharing 97% and 94% amino acid homology to GLP-1, respectively [ Figure 2 , Table 1 ]

They overlap rather than compete

Evidence-based treatments focus on improving function, reducing pain, and enhancing quality of life rather than seeking a cure, as fibromyalgia is a chronic condition requiring long-term management strategies

Coupled with the overall rise in GLP-1 RA-related discussions after the 2021 FDA approval of semaglutide for weight loss, we identify a high public interest in the use of these medications for weight management, despite their original intended use in diabetes